We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
-$27.1M
Cap. Flow
-$37.7M
Cap. Flow %
-15.33%
Top 10 Hldgs %
36.95%
Holding
116
New
41
Increased
15
Reduced
17
Closed
34

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$10.8M
2
ELV icon
Elevance Health
ELV
+$9.58M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$7.09M
4
GILD icon
Gilead Sciences
GILD
+$4.44M
5
ILMN icon
Illumina
ILMN
+$3.65M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$14.5M
2
CI icon
Cigna
CI
+$13.2M
3
MDT icon
Medtronic
MDT
+$7.5M
4
BAX icon
Baxter International
BAX
+$6.8M
5
LLY icon
Eli Lilly
LLY
+$5.65M

Sector Composition

Rank Sector Weight
1 Healthcare 78.04%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMMU
76
DELISTED
Immunomedics Inc
IMMU
$522K 0.21%
+225,000
New +$752K
LAB icon
77
Standard BioTools
LAB
$309M
$452K 0.18%
50,000
-50,000
-50% -$470K
EXEL icon
78
CALL
Exelixis
EXEL
$12.7B
$391K 0.16%
+50,000
New +$288K
NVAX icon
79
PUT
Novavax
NVAX
$1.31B
$364K 0.15%
+2,500
New +$287K
RIGL icon
80
Rigel Pharmaceuticals
RIGL
$785M
$335K 0.14%
+15,000
New +$373K
SCYX icon
81
SCYNEXIS
SCYX
$48.1M
$271K 0.11%
1,563
– –
RIGL icon
82
CALL
Rigel Pharmaceuticals
RIGL
$785M
$112K 0.05%
+5,000
New +$124K
ALNY icon
83
PUT
Alnylam Pharmaceuticals
ALNY
$29.6B
– –
-25,000
Closed -$1.57M
AXDX
84
CALL
DELISTED
Accelerate Diagnostics
AXDX
– –
-2,500
Closed -$359K
BIIB icon
85
CALL
Biogen
BIIB
$30.1B
– –
-20,000
Closed -$5.21M
BKD icon
86
Brookdale Senior Living
BKD
$3B
– –
-125,000
Closed -$1.99M
BLUE
87
DELISTED
bluebird bio
BLUE
– –
-1,930
Closed -$1.06M
BMRN icon
88
BioMarin Pharmaceuticals
BMRN
$13.5B
– –
-30,000
Closed -$2.47M
BMY icon
89
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-50,000
Closed -$3.19M
CI icon
90
Cigna
CI
$72.4B
– –
-100,000
Closed -$13.2M
DVAX
91
DELISTED
Dynavax Technologies
DVAX
– –
-140,000
Closed -$2.69M
INCY icon
92
CALL
Incyte
INCY
$24.5B
– –
-40,000
Closed -$2.9M
LLY icon
93
Eli Lilly
LLY
$1.08T
– –
-75,000
Closed -$5.65M
MDT icon
94
Medtronic
MDT
$116B
– –
-100,000
Closed -$7.5M
MRK icon
95
PUT
Merck
MRK
$322B
– –
-52,400
Closed -$2.65M
OEF icon
96
PUT
iShares S&P 100 ETF
OEF
$20.4B
– –
-100,000
Closed -$11.1M
PBYI icon
97
Puma Biotechnology
PBYI
$453M
– –
-30,000
Closed -$881K
REGN icon
98
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-7,500
Closed -$2.7M
REGN icon
99
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
– –
-7,500
Closed -$2.7M
SPY icon
100
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-50,000
Closed -$10.3M
1 2 3
4
5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2016 Portfolio in Review

As of Q2 2016, Iguana Healthcare Management held 116 positions worth $246M, down 9.9% from $273M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Iguana Healthcare Management withdrew a net $37.7M in Q2 2016, closing 34 positions and reducing 17 holdings. Its most notable exit was Cigna, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 68% a quarter earlier, followed by Industrials.

Against the trend, Iguana Healthcare Management opened a new position in Shire pic worth $11M.

  • Iguana Healthcare Management's largest Q2 2016 buy was Shire pic: 60,000 shares worth $11M.
  • Iguana Healthcare Management added most to Gilead Sciences in Q2 2016, an estimated $4.44M increase.
  • Iguana Healthcare Management's biggest Q2 2016 reduction was MEDIVATION, INC., cutting an estimated $14.5M.
  • Iguana Healthcare Management fully exited Cigna in Q2 2016, selling an estimated $13.2M.
  • Iguana Healthcare Management's ten largest holdings make up 37% of its $246M portfolio in Q2 2016.
  • Iguana Healthcare Management opened 41 new positions and closed 34 in Q2 2016.
  • Iguana Healthcare Management's portfolio value fell 9.9% quarter-over-quarter to $246M.

Based on Iguana Healthcare Management's 13F filing for Q2 2016, filed 15 Aug 2016.